Skip to content

TeleRehabilitation Following ACL Reconstruction

TeleRehabilitation Following ACL Reconstruction

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04541940
Enrollment
16
Registered
2020-09-09
Start date
2020-10-01
Completion date
2021-11-30
Last updated
2022-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ACL Injury

Brief summary

Telerehabilitation is a form of tele-treatment in which rehabilitation services are dispensed at patients' home utilizing video telecommunication services with real-time synchronous exchange of information. The advantages of telerehabilitation include reducing unnecessary travel to the hospital and person to person contact while maintaining social distancing. While some of the patients are truly staying at remote areas, others are unable to manage travel in the lockdown period. Telemedicine offers the opportunity to deliver rehabilitative services in the patients' home, closing geographic, physical, and motivational gaps. Punctuality on either side is also assured since the travel times are saved on both the ends. The purpose of the proposed study is to evaluate telerehabilitation vs. in-person rehabilitation following ACL reconstruction. Objectives include assess return to sport and patient reported functional outcomes.

Interventions

Rehabilitation services will be dispensed at patients' home utilizing video telecommunication services with real-time synchronous exchange of information - Quadriceps isometrics exercises, straight leg raises, and range of motion exercises.

Quadriceps isometrics exercises, straight leg raises, and range of motion exercises.

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Scheduled for ACL reconstruction * Age 18-40 * Ability to comply with a standardized postoperative protocol * Willing and able to provide consent

Exclusion criteria

* Pregnant patient * Age \>40 years, or \< 18 * Previous knee surgery * Unable to speak English or perform informed consent

Design outcomes

Primary

MeasureTime frameDescription
RTS (Return to Sport)up to 1 year post-opThe day when the participant is able to fully participate in their sport, but not at their desired performance level.

Secondary

MeasureTime frameDescription
ACL-RSI Questionnaire Scoreup to 1 year post-opACL-RSI (anterior cruciate ligament - return to sport) consists of 12 questions. Each question is scored 0-100 with a total range of 0-1200. The higher the score, the more positive psychological outlook a participant has.
Visual Analogue Scale (VAS) Scoreup to 1 year post-opVAS is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between no pain and worst pain. The total score ranges from 0-10. The higher the score, the worse the pain.
Knee Injury and Osteoarthritis Outcome Score (KOOS)up to 1 year post-opKOOS is a knee-specific instrument, developed to assess the participants' opinion about their knee and associated problems. The KOOS evaluates both short-term and long-term consequences of knee injury. It holds 42 items in 5 separately scored subscales. Each subscale is calculated independently. The calculated mean score of the individual items of each subscale will be divided by 4. The total score range is 0-100. The lower the score, the more extreme the problems.
International Knee Documentation Committee (IKDC) Scoreup to 1 year post-opThe IKDC is a patient-completed tool, which contains sections on knee symptoms (7 items), function (2 items), and sports activities (2 items). Scores range from 0 points (lowest level of function or highest level of symptoms) to 100 points (highest level of function and lowest level of symptoms).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026